• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴侣蛋白与蛋白质稳态:在帕金森病中的作用

Chaperones and Proteostasis: Role in Parkinson's Disease.

作者信息

Joshi Neha, Raveendran Atchaya, Nagotu Shirisha

机构信息

Organelle Biology and Cellular Ageing Lab, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.

出版信息

Diseases. 2020 Jun 22;8(2):24. doi: 10.3390/diseases8020024.

DOI:10.3390/diseases8020024
PMID:32580484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7349525/
Abstract

Proper folding to attain a defined three-dimensional structure is a prerequisite for the functionality of a protein. Improper folding that eventually leads to formation of protein aggregates is a hallmark of several neurodegenerative disorders. Loss of protein homeostasis triggered by cellular stress conditions is a major contributing factor for the formation of these toxic aggregates. A conserved class of proteins called chaperones and co-chaperones is implicated in maintaining the cellular protein homeostasis. Expanding the body of evidence highlights the role of chaperones as central mediators in the formation, de-aggregation and degradation of the aggregates. Altered expression and function of chaperones is associated with many neurodegenerative diseases including Parkinson's disease. Several studies indicate that chaperones are at the center of the cause and effect cycle of this disease. An overview of the various chaperones that are associated with homeostasis of Parkinson's disease-related proteins and their role in pathogenicity will be discussed in this review.

摘要

正确折叠以获得确定的三维结构是蛋白质发挥功能的前提条件。最终导致蛋白质聚集体形成的错误折叠是几种神经退行性疾病的标志。细胞应激条件引发的蛋白质稳态丧失是这些有毒聚集体形成的主要促成因素。一类被称为伴侣蛋白和共伴侣蛋白的保守蛋白质与维持细胞蛋白质稳态有关。越来越多的证据表明,伴侣蛋白在聚集体的形成、解聚和降解中起着核心介导作用。伴侣蛋白表达和功能的改变与包括帕金森病在内的许多神经退行性疾病有关。几项研究表明,伴侣蛋白处于这种疾病因果循环的中心。本文将综述与帕金森病相关蛋白质稳态相关的各种伴侣蛋白及其在致病性中的作用。

相似文献

1
Chaperones and Proteostasis: Role in Parkinson's Disease.伴侣蛋白与蛋白质稳态:在帕金森病中的作用
Diseases. 2020 Jun 22;8(2):24. doi: 10.3390/diseases8020024.
2
Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.应用伴侣蛋白治疗蛋白质错误折叠疾病:帕金森病中α-突触核蛋白的分子伴侣。
Int J Biol Macromol. 2013 Sep;60:196-205. doi: 10.1016/j.ijbiomac.2013.05.032. Epub 2013 Jun 5.
3
Molecular chaperones in Parkinson's disease--present and future.帕金森病中的分子伴侣:现状与未来。
J Parkinsons Dis. 2011;1(4):299-320.
4
The Role of Co-chaperones in Synaptic Proteostasis and Neurodegenerative Disease.共伴侣蛋白在突触蛋白质稳态和神经退行性疾病中的作用
Front Neurosci. 2017 May 19;11:248. doi: 10.3389/fnins.2017.00248. eCollection 2017.
5
Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.蛋白质稳态和 ATP 非依赖型分子伴侣对细胞内外蛋白质聚集的调控:晶状体α-晶体蛋白和乳清蛋白。
Acc Chem Res. 2018 Mar 20;51(3):745-752. doi: 10.1021/acs.accounts.7b00250. Epub 2018 Feb 14.
6
Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.热休克蛋白 90 及其共伴侣在神经退行性疾病中的作用。
Int J Mol Sci. 2019 Oct 9;20(20):4976. doi: 10.3390/ijms20204976.
7
Proteomic analysis of protein homeostasis and aggregation.蛋白质组学分析蛋白质平衡和聚集。
J Proteomics. 2019 Apr 30;198:98-112. doi: 10.1016/j.jprot.2018.12.003. Epub 2018 Dec 6.
8
Walking the tightrope: proteostasis and neurodegenerative disease.走钢丝:蛋白质稳态与神经退行性疾病
J Neurochem. 2016 May;137(4):489-505. doi: 10.1111/jnc.13575. Epub 2016 Mar 8.
9
Secreted Chaperones in Neurodegeneration.神经退行性变中的分泌伴侣蛋白
Front Aging Neurosci. 2020 Aug 27;12:268. doi: 10.3389/fnagi.2020.00268. eCollection 2020.
10
Preventing α-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins.预防α-突触核蛋白聚集:小分子热休克分子伴侣蛋白的作用
Biochim Biophys Acta. 2014 Sep;1842(9):1830-43. doi: 10.1016/j.bbadis.2014.06.024. Epub 2014 Jun 26.

引用本文的文献

1
The quest for Parkinson's disease biomarkers: traditional and emerging multi-omics approaches.帕金森病生物标志物的探索:传统与新兴的多组学方法
Mol Biol Rep. 2025 Aug 16;52(1):831. doi: 10.1007/s11033-025-10929-x.
2
Single nucleus RNA sequencing profile analysis to reveal cell type specific common molecular drivers of Parkinson's disease and therapeutic agents.单核RNA测序图谱分析以揭示帕金森病的细胞类型特异性常见分子驱动因素及治疗药物。
Sci Rep. 2025 Jul 25;15(1):27086. doi: 10.1038/s41598-025-09417-w.
3
The Yeast Parkinson's Disease Model Exhibits An Increase in Peroxisome Number Independent of the Division Proteins Vps1 and Dnm1.

本文引用的文献

1
Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?铜离子与帕金森病:为何体内平衡如此重要?
Biomolecules. 2020 Jan 29;10(2):195. doi: 10.3390/biom10020195.
2
LRRK2 in Parkinson disease: challenges of clinical trials.LRRK2 在帕金森病中的作用:临床试验面临的挑战。
Nat Rev Neurol. 2020 Feb;16(2):97-107. doi: 10.1038/s41582-019-0301-2. Epub 2020 Jan 24.
3
Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.线粒体在帕金森病发病机制中的细胞器间交流失调。
酵母帕金森病模型显示过氧化物酶体数量增加,且与分裂蛋白Vps1和Dnm1无关。
Mol Neurobiol. 2025 Jul 24. doi: 10.1007/s12035-025-05236-2.
4
The Emerging Role of the Molecular Chaperone Clusterin in Parkinson's Disease.分子伴侣簇集蛋白在帕金森病中的新作用
Int J Mol Sci. 2025 Jul 1;26(13):6351. doi: 10.3390/ijms26136351.
5
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.基于网络的系统遗传学框架揭示帕金森病的病理生物学及药物再利用
NPJ Parkinsons Dis. 2025 Jan 22;11(1):22. doi: 10.1038/s41531-025-00870-y.
6
Positron emission tomography tracers for synucleinopathies.用于突触核蛋白病的正电子发射断层扫描示踪剂。
Mol Neurodegener. 2025 Jan 5;20(1):1. doi: 10.1186/s13024-024-00787-9.
7
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.一种基于网络的系统遗传学框架识别帕金森病中的病理生物学和药物再利用。
Res Sq. 2024 Oct 14:rs.3.rs-4869009. doi: 10.21203/rs.3.rs-4869009/v1.
8
α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.α-突触核蛋白菌株及其与帕金森病、多系统萎缩和路易体痴呆的关系。
Int J Mol Sci. 2023 Jul 28;24(15):12134. doi: 10.3390/ijms241512134.
9
Sporadic SNCA mutations A18T and A29S exhibit variable effects on protein aggregation, cell viability and oxidative stress.散发的 SNCA 突变 A18T 和 A29S 对蛋白质聚集、细胞活力和氧化应激的影响不同。
Mol Biol Rep. 2023 Jul;50(7):5547-5556. doi: 10.1007/s11033-023-08457-7. Epub 2023 May 8.
10
LRRK2 and Proteostasis in Parkinson's Disease.LRRK2 与帕金森病中的蛋白稳态
Int J Mol Sci. 2022 Jun 18;23(12):6808. doi: 10.3390/ijms23126808.
Cells. 2020 Jan 17;9(1):233. doi: 10.3390/cells9010233.
4
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.LRRK2 生物学:从结构到功能障碍:研究进展,但主题不变。
Mol Neurodegener. 2019 Dec 21;14(1):49. doi: 10.1186/s13024-019-0344-2.
5
Human Molecular Chaperone Hsp60 and Its Apical Domain Suppress Amyloid Fibril Formation of α-Synuclein.人分子伴侣 Hsp60 及其顶端结构域抑制α-突触核蛋白的淀粉样纤维形成。
Int J Mol Sci. 2019 Dec 19;21(1):47. doi: 10.3390/ijms21010047.
6
Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.热休克蛋白 90 及其共伴侣在神经退行性疾病中的作用。
Int J Mol Sci. 2019 Oct 9;20(20):4976. doi: 10.3390/ijms20204976.
7
Interaction between Copper Chaperone Atox1 and Parkinson's Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells.铜伴侣 Atox1 与帕金森病蛋白 α-突触核蛋白的相互作用包括金属结合位点,并发生在活细胞中。
ACS Chem Neurosci. 2019 Nov 20;10(11):4659-4668. doi: 10.1021/acschemneuro.9b00476. Epub 2019 Oct 24.
8
The genetic architecture of Parkinson's disease.帕金森病的遗传结构。
Lancet Neurol. 2020 Feb;19(2):170-178. doi: 10.1016/S1474-4422(19)30287-X. Epub 2019 Sep 11.
9
The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells.分子伴侣 DNAJB6 而非 DNAJB1 抑制细胞内 α-突触核蛋白的种子聚集。
Int J Mol Sci. 2019 Sep 11;20(18):4495. doi: 10.3390/ijms20184495.
10
Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles.α-突触核蛋白结构与帕金森病——相关研究进展和新兴原理
Mol Neurodegener. 2019 Jul 22;14(1):29. doi: 10.1186/s13024-019-0329-1.